Publication | Open Access
Oncogenic BRAF fusions in mucosal melanomas activate the MAPK pathway and are sensitive to MEK/PI3K inhibition or MEK/CDK4/6 inhibition
93
Citations
47
References
2017
Year
MedicineReceptor Tyrosine KinaseMelanomaOncogenic Braf FusionsMapk PathwayRadiation OncologyCancer BiologyCell BiologyCell SignalingTumor BiologyMucosal MelanomasSkin Cancer
| Year | Citations | |
|---|---|---|
Page 1
Page 1